Table 1.
Patient data
| Baseline Data |
Bodily Composition |
Radiographic Evaluation |
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Height, cm | Weight, kg |
BMI, kg/m2 |
Thigh Circumference, cm |
Type* | JIC Stage: Tx Side† |
JIC Stage: Non-Tx Side† |
||||||||||||||||||
| Group | Patient No. | Age, years | Sex | TS | History | Brinkman index | SU | Pre-Tx | 1Y | 10Y | Pre-Tx | 1Y | 10Y | Pre-Tx | 1Y | 10Y | Pre-Tx | 1Y | 10Y | Pre-Tx | 1Y | 10Y | ||
| Stable group | 2 | 23 | M | L | Cushing syndrome | 0 | Y | 171.0 | 56.6 | 57.6 | 60.2 | 19.4 | 19.7 | 20.6 | 39.0 | 38.5 | 41.0 | C2 | 3A | 3A | 3A | 2 | 2 | 2 |
| 4 | 20 | M | R | Hepatitis | 0 | Y | 174.2 | 76.8 | 72.9 | 70.6 | 25.3 | 24.0 | 23.3 | 50.5 | 50.0 | 53.5 | C1 | 3A | 3A | 3A | 2 | 2 | 2 | |
| 5 | 35 | M | L | None | 300 | N | 178.8 | 70.0 | 59.2 | 62.0 | 21.9 | 18.5 | 19.4 | 43.2 | 38.5 | 38.0 | C2 | 3A | 3A | 3A | THA | THA | THA | |
| 9 | 33 | M | R | None | 0 | N | 174.2 | 61.0 | 65.7 | 70.0 | 20.1 | 21.7 | 23.1 | 42.5 | 42.5 | 44.0 | C2 | 3A | 3A | 3A | 1 | 1 | 1 | |
| 10 | 38 | M | R | None | 300 | N | 166.7 | 52.9 | 52.5 | 54.4 | 19.0 | 18.9 | 19.6 | 40.0 | 38.7 | 38.5 | C2 | 3A | 3A | 3A | 3A | 3B | THA | |
| Progressed group | 1 | 27 | M | R | Nephritis | 300 | Y | 170.9 | 66.5 | 68.7 | 62.0 | 22.8 | 23.5 | 21.2 | 42.5 | 42.0 | 41.0 | C2 | 3B | 3B | 4 | 2 | 2 | 2 |
| 6 | 28 | M | R | None | 300 | N | 169.2 | 58.3 | 63.9 | 53.4 | 20.4 | 22.3 | 18.7 | 40.0 | 44.2 | 42.5 | C2 | 3A | 3A | 4 | 2 | 2 | 2 | |
| 8 | 26 | M | R | None | 105 | N | 175.1 | 66.4 | 73.4 | 65.0 | 21.7 | 23.9 | 21.2 | 44.0 | 47.2 | 46.5 | C2 | 3B | 3B | 4 | 4 | 4 | 4 | |
| 3 | 48 | M | R | Meningioma | 72 | N | 174.7 | 87.5 | 69.6 | 84.0 | 28.7 | 22.8 | 27.5 | 46.2 | 40.0 | 41.0 | C2 | 3B | 3B | THA | 2 | 2 | 2 | |
| 7 | 39 | M | R | Leukemia | 0 | Y | 183.1 | 85.2 | 85.4 | 80.9 | 25.4 | 25.5 | 24.1 | 50.2 | 49.8 | 47.0 | C2 | 3B | 3B | THA | 2 | 3A | THA | |
Abbreviations: BMI, body mass index; L, left; M, male; N, no; R, right; SU, steroid use; THA, total hip arthroplasty; TS, treatment side; Tx, treatment; Y, yes.
Radiogenic classification Japanese Investigation Committee.
Modified version of the radiographic staging system proposed by the American Research Circulation Osseous Committee.